BDBM283250 4-[2-(4-amino-piperidin-1-yl)-1- methyl-5-(1-methyl-1H-indazol-5- yl)-6-oxo-1,6-dihydro-pyrimidin- 4-yl]-2-fluoro-benzonitrile::US10023543, Example 35::US10207999, Example 35::US10328077, Example 35::US10548896, Example 35::US10849898, Example 35::US10960005, Example 35::US11084793, Example 35::US9573930, Example 35::US9771329, Example 35::US9776974, Example 35

SMILES Cn1ncc2cc(ccc12)-c1c(nc(N2CCC(N)CC2)n(C)c1=O)-c1ccc(C#N)c(F)c1

InChI Key InChIKey=IEOVVTJCXFEDKK-UHFFFAOYSA-N

Data  12 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 283250   

TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Celgene Quanticel Research

US Patent
LigandPNGBDBM283250(4-[2-(4-amino-piperidin-1-yl)-1- methyl-5-(1-methy...)
Affinity DataIC50: <100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent